日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Ly6g(high) Neutrophil Subset Dictates Breast Cancer Lung Metastasis via CD8(+) T Cell Death.

Ly6g(高)中性粒细胞亚群通过CD8(+)T细胞死亡决定乳腺癌肺转移。

Wang Rui, Liu Xiaoqi, Hou Yixuan, Chen Shanchun, Liu Yongcan, Lu Zexiu, Chang Chao, Meng Die, Chen Jing, Cui Xiaojiang, Shi Zhengrong, Wan Xueying, Liu Manran

ACSL5 Mediates Adaptation to the Palmitic Acid-Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis

ACSL5介导对富含棕榈酸的肺微环境的适应,从而增强转移性乳腺癌细胞的存活和肺转移

Chen, Shanchun; Chang, Chao; Liu, Xiaoqi; Wang, Rui; Liu, Yongcan; Meng, Die; Wang, Boxuan; Hai, Yuhang; Deng, Chaoqun; Tong, Yanran; Cui, Xiaojiang; Wen, Siyang; Yin, Guobing; Liu, Manran

Developing an antibody drug encapsulation nanoagent targeting HER2 for cancer treatment

开发靶向HER2的抗体药物封装纳米制剂用于癌症治疗

Li, Linrong; Yao, Ru; Liu, Yan; Almeyda, Nelyda Gonzalez; Sun, Qiang; Huang, Faqing; Wang, Leslie; Wang, Kinsley; Turkson, James; Medina-Kauwe, Lali; Giuliano, Armando; Yu, Changjun; Cui, Xiaojiang

Benchmarking large language models for identifying transcription factor regulatory interactions

对大型语言模型进行基准测试,以识别转录因子调控相互作用

Noel, Lake; Hsiao, Yi-Wen; He, Yimeng; Hung, Andrew; Cui, Xiaojiang; Ray, Edward; Moore, Jason H; Peng, Pei-Chen; Huang, Xiuzhen

Tumor derived cell-free nucleic acid upregulates programmed death-ligand 1 expression in neutrophil via intracellular Toll-like receptor signaling

肿瘤来源的游离核酸通过细胞内Toll样受体信号通路上调中性粒细胞中程序性死亡配体1的表达

Saito, Suguru; Cao, Duo-Yao; Shibata, Tomohiro; Liu, Yan; Otagiri-Hoshi, Aoi; Cui, Xiaojiang; Bernstein, Kenneth E

PCBP2 Mediates Olaparib Resistance in Breast Cancer by Inhibiting m6A Methylation to Stabilize PARP1 mRNA.

PCBP2 通过抑制 m6A 甲基化稳定 PARP1 mRNA 来介导乳腺癌中的奥拉帕尼耐药性。

Qi Zhaochang, He Lifang, Xu Zemei, Luo Xi, Ji Likeng, Lin Chenting, Giuliano Armando E, Cui Xiaojiang, Deng Zihao, Wu Jundong, Lin Stanley Li, Cui Yukun

Corrigendum for "Oxidized ATM-mediated glycolysis enhancement in breast cancer-associated fibroblasts contributes to tumor invasion through lactate as metabolic coupling" [eBioMedicine 41 (2019) 370-383]

对“氧化 ATM 介导的乳腺癌相关成纤维细胞糖酵解增强通过乳酸代谢偶联促进肿瘤侵袭”的更正 [eBioMedicine 41 (2019) 370-383]

Sun, Kexin; Tang, Shifu; Hou, Yixuan; Xi, Lei; Chen, Yanlin; Yin, Jiali; Peng, Meixi; Zhao, Maojia; Cui, Xiaojiang; Liu, Manran

Reversal of endocrine resistance via N6AMT1-NEDD4L pathway-mediated p110α degradation.

通过 N6AMT1-NEDD4L 通路介导的 p110α 降解逆转内分泌抵抗

Ji Likeng, Chen Jiongyu, He Lifang, Zhang Fan, Deng Zihao, Lin Jiediao, Qi Zhaochang, Luo Xi, Giuliano Armando E, Cui Xiaojiang, Lin Stanley Li, Cui Yukun

Targeted Treatment of Sarcomas by Single Protein Encapsulated Doxorubicin with Undetectable Cardiotoxicity and Superior Efficacy.

采用单蛋白包裹的阿霉素靶向治疗肉瘤,具有无法检测的心脏毒性和优异的疗效

Yu Changjun, Huang Faqing, Wang Leslie, Liu Mengmeng, Chow Warren A, Ling Xiang, Li Fengzhi, Cook-Wiens Galen, Li Linrong, Cui Xiaojiang

Overcoming Resistance in Prostate Cancer Therapy Using a DZ-Simvastatin Conjugate

利用DZ-辛伐他汀偶联物克服前列腺癌治疗中的耐药性

Ou, Yan; Chu, Gina Chia-Yi; Lyu, Ji; Yin, Liyuan; Lim, Adrian; Zhai, Ning; Cui, Xiaojiang; Lewis, Michael S; Edderkaoui, Mouad; Pandol, Stephen J; Wang, Ruoxiang; Zhang, Yi